Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Growth”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04398914
What this trial is testing

Pyrotinib, Trastuzumab, Pertuzumab and Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer

Who this might be right for
Breast Cancer Invasive
Shanghai Jiao Tong University School of Medicine 216
Early research (Phase 1)Study completedNCT00491855
What this trial is testing

Oxaliplatin and Paclitaxel Plus Bevacizumab in Advanced Peritoneal Carcinomatosis

Who this might be right for
Peritoneal Cancer
M.D. Anderson Cancer Center 3
Early research (Phase 1)Study completedNCT02345174
What this trial is testing

Immuno Positron Emission Tomography Study of GSK2849330 in Subjects With Human Epidermal Growth Factor Receptor 3-Positive Solid Tumors

Who this might be right for
CancerNeoplasms
GlaxoSmithKline 6
Testing effectiveness (Phase 2)Study completedNCT03219476
What this trial is testing

Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Node-Negative Breast Cancer

Who this might be right for
Breast CancerInvasive Breast Cancer
Medical College of Wisconsin 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT03769103
What this trial is testing

Study of Osimertinib + SRS vs Osimertinib Alone for Brain Metastases in EGFR Positive Patients With NSCLC

Who this might be right for
Lung Cancer Non-small Cell Stage IVBrain Metastases
British Columbia Cancer Agency 40
Large-scale testing (Phase 3)Active Not RecruitingNCT05338970
What this trial is testing

HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy

Who this might be right for
Nonsquamous Non-small Cell Lung CancerEGFR L858REGFR Exon 19 Deletion
Daiichi Sankyo 586
Testing effectiveness (Phase 2)Ended earlyNCT03709082
What this trial is testing

Palbociclib in Estrogen Receptor Positive (ER+) Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer

Who this might be right for
HER2-positive Breast CancerBreast Cancer Metastatic
University of Kansas Medical Center 3
Large-scale testing (Phase 3)UnknownNCT00657423
What this trial is testing

Impact of Endostar Combined With Chemotherapy on the Angiogenesis of Advanced Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung Neoplasms
Xijing Hospital 80
Early research (Phase 1)Study completedNCT04991480
What this trial is testing

ART4215 for the Treatment of Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced CancerMetastatic CancerBreast Cancer
Artios Pharma Ltd 93
Testing effectiveness (Phase 2)WithdrawnNCT01427205
What this trial is testing

Phase II Study of Cetuximab With or Without OSI-906 in Head and Neck Squamous Cell Carcinoma (HNSCC)

Who this might be right for
Head and Neck Cancer
M.D. Anderson Cancer Center
Early research (Phase 1)WithdrawnNCT01182883
What this trial is testing

A Phase I Study of IMC-A12 in Combination With Temsirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors

Who this might be right for
Brain Stem NeoplasmsGliomaPinealoma
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00965250
What this trial is testing

Multicenter Phase II Study of IMC-A12 in Patients With Thymoma and Thymic Carcinoma Who Have Been Previously Treated With Chemotherapy

Who this might be right for
ThymomaThymic CarcinomaThymic Carcinoid+1 more
National Cancer Institute (NCI) 49
Testing effectiveness (Phase 2)Study completedNCT01866410
What this trial is testing

Cabozantinib-S-Malate and Erlotinib Hydrochloride in Treating Patients With Previously Treated Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage IV Non-Small Cell Lung Cancer AJCC v7
National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Study completedNCT01664182
What this trial is testing

Trebananib With or Without Bevacizumab, Pazopanib Hydrochloride, Sorafenib Tosylate, or Sunitinib Malate in Treating Patients With Advanced Kidney Cancer

Who this might be right for
Advanced Renal Cell CarcinomaAdvanced Sarcomatoid Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v7+1 more
National Cancer Institute (NCI) 41
Early research (Phase 1)Study completedNCT01916447
What this trial is testing

A Phase I Study of TAS-102 in Patients With Advanced Gastrointestinal Tumors.

Who this might be right for
Advanced Gastrointestinal Tumors
Taiho Oncology, Inc. 65
Early research (Phase 1)Looking for participantsNCT07224776
What this trial is testing

Sparsentan for the Treatment of VEGF Signaling Pathway Inhibitor-Associated Proteinuria

Who this might be right for
Proteinuric Renal DiseaseProteinuric Kidney DiseaseProteinuria+1 more
Brigham and Women's Hospital 20
Not applicableStudy completedNCT02731313
What this trial is testing

Human Epidermal Growth Factor Receptor 2 (HER-2) Status in Gastric and Gastro-Esophageal Junction (GEJ) Carcinoma

Who this might be right for
Gastric Cancer, Gastroesophageal Junction Cancer
Hoffmann-La Roche 420
Not applicableStudy completedNCT01469754
What this trial is testing

Longitudinal Survey Analysis in Lymphoma Survivors

Who this might be right for
LymphomaPosttraumatic Stress DisorderPosttraumatic Growth+2 more
Weill Medical College of Cornell University 97
Testing effectiveness (Phase 2)Ended earlyNCT03584009
What this trial is testing

A Phase II Study Comparing The Efficacy Of Venetoclax + Fulvestrant Vs. Fulvestrant In Women With Estrogen Receptor-Positive, Her2-Negative Locally Advanced Or Metastatic Breast Cancer Who Experienced Disease Recurrence Or Progression During Or After CDK4/6 Inhibitor Therapy

Who this might be right for
Estrogen Receptor-positive (ER+)/Human Epidermal Growth Factor Receptor (HER2)-Negative Locally Advanced or Metastatic Breast Cancer
Hoffmann-La Roche 103
Not applicableUnknownNCT01527409
What this trial is testing

The Efficacy of Health Partnership Program for Cancer Patients

Who this might be right for
Breast CancerColon CancerGastric Cancer+1 more
National Cancer Center, Korea 248
Next Page